Gian Paolo Bentivoglio, MD | |
154 Duchess Ave, Northeast Kingdom Human Services, Newport, VT 05855-5516 | |
(802) 334-6744 | |
(802) 334-7340 |
Full Name | Gian Paolo Bentivoglio |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 34 Years |
Location | 154 Duchess Ave, Newport, Vermont |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417023573 | NPI | - | NPPES |
ORE3322 | Medicaid | VT |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northeast Kingdom Human Services Inc | 0941276703 | 13 |
News Archive
Boehringer Ingelheim presented today the first data from the Phase III UniTinA-asthma program. In two studies, presented at the 2012 European Respiratory Society (ERS) Congress in Vienna, Austria, tiotropium delivered once daily via the Respimat inhaler significantly improved lung function and reduced asthma exacerbations in patients who remained symptomatic on current treatment with at least high dose inhaled corticosteroids (ICS) and long-acting beta agonists (LABA).
Researchers who analyzed data for São Paulo state, Brazil, found the highest rates of newborn mortality from asphyxia in cities in the south, southeast and north of the state between 2004 and 2013.
Mayo Clinic today announced plans to establish the Mayo Clinic Proton Beam Therapy Program as part of Mayo's national three-site cancer center in Minnesota, Arizona and Florida. The new program will employ intensity modulated proton therapy — based on pencil beam scanning — which is a more precise form of proton therapy treatment that allows greater control over radiation doses, shorter treatment times and fewer side effects. It is also believed to be more cost effective in selected patients.
Cardio3 BioSciences, a leader in engineered cell therapies with clinical programs initially targeting indications in cardiovascular disease and oncology, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a significant patent application covering T-Cell receptor-deficient T-Cells which are engineered to express a chimeric antigen receptor.
› Verified 5 days ago
Entity Name | Northeast Kingdom Human Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043372709 PECOS PAC ID: 0941276703 Enrollment ID: O20041012001355 |
News Archive
Boehringer Ingelheim presented today the first data from the Phase III UniTinA-asthma program. In two studies, presented at the 2012 European Respiratory Society (ERS) Congress in Vienna, Austria, tiotropium delivered once daily via the Respimat inhaler significantly improved lung function and reduced asthma exacerbations in patients who remained symptomatic on current treatment with at least high dose inhaled corticosteroids (ICS) and long-acting beta agonists (LABA).
Researchers who analyzed data for São Paulo state, Brazil, found the highest rates of newborn mortality from asphyxia in cities in the south, southeast and north of the state between 2004 and 2013.
Mayo Clinic today announced plans to establish the Mayo Clinic Proton Beam Therapy Program as part of Mayo's national three-site cancer center in Minnesota, Arizona and Florida. The new program will employ intensity modulated proton therapy — based on pencil beam scanning — which is a more precise form of proton therapy treatment that allows greater control over radiation doses, shorter treatment times and fewer side effects. It is also believed to be more cost effective in selected patients.
Cardio3 BioSciences, a leader in engineered cell therapies with clinical programs initially targeting indications in cardiovascular disease and oncology, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a significant patent application covering T-Cell receptor-deficient T-Cells which are engineered to express a chimeric antigen receptor.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Gian Paolo Bentivoglio, MD Po Box 724, Northeast Kingdom Human Services, Newport, VT 05855-0724 Ph: (802) 334-6744 | Gian Paolo Bentivoglio, MD 154 Duchess Ave, Northeast Kingdom Human Services, Newport, VT 05855-5516 Ph: (802) 334-6744 |
News Archive
Boehringer Ingelheim presented today the first data from the Phase III UniTinA-asthma program. In two studies, presented at the 2012 European Respiratory Society (ERS) Congress in Vienna, Austria, tiotropium delivered once daily via the Respimat inhaler significantly improved lung function and reduced asthma exacerbations in patients who remained symptomatic on current treatment with at least high dose inhaled corticosteroids (ICS) and long-acting beta agonists (LABA).
Researchers who analyzed data for São Paulo state, Brazil, found the highest rates of newborn mortality from asphyxia in cities in the south, southeast and north of the state between 2004 and 2013.
Mayo Clinic today announced plans to establish the Mayo Clinic Proton Beam Therapy Program as part of Mayo's national three-site cancer center in Minnesota, Arizona and Florida. The new program will employ intensity modulated proton therapy — based on pencil beam scanning — which is a more precise form of proton therapy treatment that allows greater control over radiation doses, shorter treatment times and fewer side effects. It is also believed to be more cost effective in selected patients.
Cardio3 BioSciences, a leader in engineered cell therapies with clinical programs initially targeting indications in cardiovascular disease and oncology, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a significant patent application covering T-Cell receptor-deficient T-Cells which are engineered to express a chimeric antigen receptor.
› Verified 5 days ago
Dr. Elliot Martin Kaufman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 154 Duchess Ave, Newport, VT 05855 Phone: 802-334-6744 Fax: 802-334-7450 | |
Dr. Richard D Edelstein, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 154 Duchess Street, Newport, VT 05855 Phone: 802-334-6744 Fax: 802-334-7450 | |
Dr. Rizwan Ul Haq, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 41 Medical Village Dr, Newport, VT 05855 Phone: 802-334-3500 |